Literature DB >> 20619251

Inhibition of human and rat 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities by perfluoroalkylated substances.

Binghai Zhao1, Guo-Xin Hu, Yanhui Chu, Xiudong Jin, Shouliang Gong, Benson T Akingbemi, Zhiqiang Zhang, Barry R Zirkin, Ren-Shan Ge.   

Abstract

Perfluoroalkylated substances (PFASs) including perfluorooctane acid (PFOA) and perfluorooctane sulfonate (PFOS) have been classified as persistent organic pollutants and are known to cause reduced testosterone production in human males. The objective of the present study was to compare the potencies of five different PFASs including PFOA, PFOS, potassium perfluorooctane sulfonate (PFOSK), potassium perfluorohexane sulfonate (PFHxSK) and potassium perfluorobutane sulfonate (PFBSK) in the inhibition of 3beta-hydroxysteroid dehydrogenase (3beta-HSD) and 17beta-hydroxysteroid dehydrogenase 3 (17beta-HSD3) activities in the human and rat testes. Human and rat microsomal enzymes were exposed to various PFASs. PFOS and PFOSK inhibited rat 3beta-HSD activity with IC(50) of 1.35 + or -0.05 and 1.77 + or - 0.04 microM, respectively, whereas PFHxSK and PFBSK had no effect at concentrations up to 250 microM. All chemicals tested weakly inhibited human 3beta-HSD activity with IC(50)s over 250 microM. On the other hand, PFOS, PFOSK and PFOA inhibited human 17beta-HSD3 activity with IC(50)s of 6.02 + or - 1.02, 4.39 + or - 0.46 and 127.60 + or - 28.52 microM, respectively. The potencies for inhibition of 17beta-HSD3 activity were determined to be PFOSK>PFOS>PFOA>PFHxSK=PFBSK for human 17beta-HSD3 activity. There appears to be a species-dependent sensitivity to PFAS-mediated inhibition of enzyme activity because the IC(50)s of PFOS(K) for inhibition of rat 17beta-HSD3 activity was greater than 250 microM. In conclusion, the present study shows that PFOS and PFOSK are potent inhibitors of rat 3beta-HSD and human 17beta-HSD3 activity, and implies that inhibition of steroidogenic enzyme activity may be a contributing factor to the effects that PFASs exert on androgen secretion in the testis. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619251     DOI: 10.1016/j.cbi.2010.07.001

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  9 in total

1.  Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups.

Authors:  Weihsueh A Chiu; Kathryn Z Guyton; Matthew T Martin; David M Reif; Ivan Rusyn
Journal:  ALTEX       Date:  2017-07-24       Impact factor: 6.043

2.  Perfluoroalkyl and Polyfluoroalkyl substance exposure and association with sex hormone concentrations: Results from the NHANES 2015-2016.

Authors:  Xin Xie; Xueqiong Weng; Shan Liu; Jingmin Chen; Xinrong Guo; Xinyu Gao; Qiaoyuan Fei; Guang Hao; Chunxia Jing; Liping Feng
Journal:  Environ Sci Eur       Date:  2021-06-06       Impact factor: 5.481

3.  Exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal Leydig cells.

Authors:  Binghai Zhao; Li Li; Jieting Liu; Hongzhi Li; Chunlei Zhang; Pengfei Han; Yufei Zhang; Xiaohuan Yuan; Ren Shan Ge; Yanhui Chu
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

Review 4.  Inhibitors of testosterone biosynthetic and metabolic activation enzymes.

Authors:  Leping Ye; Zhi-Jian Su; Ren-Shan Ge
Journal:  Molecules       Date:  2011-12-02       Impact factor: 4.411

5.  Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States).

Authors:  Rachel Cluett; Shravanthi M Seshasayee; Lisa B Rokoff; Sheryl L Rifas-Shiman; Xiaoyun Ye; Antonia M Calafat; Diane R Gold; Brent Coull; Catherine M Gordon; Clifford J Rosen; Emily Oken; Sharon K Sagiv; Abby F Fleisch
Journal:  Environ Health Perspect       Date:  2019-08-21       Impact factor: 9.031

Review 6.  Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?

Authors:  Pheruza Tarapore; Bin Ouyang
Journal:  Int J Environ Res Public Health       Date:  2021-04-05       Impact factor: 4.614

Review 7.  Assessment of the Emerging Threat Posed by Perfluoroalkyl and Polyfluoroalkyl Substances to Male Reproduction in Humans.

Authors:  Leah Calvert; Mark P Green; Geoffry N De Iuliis; Matthew D Dun; Brett D Turner; Bradley O Clarke; Andrew L Eamens; Shaun D Roman; Brett Nixon
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

8.  The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study.

Authors:  Houman Goudarzi; Atsuko Araki; Sachiko Itoh; Seiko Sasaki; Chihiro Miyashita; Takahiko Mitsui; Hiroyuki Nakazawa; Katsuya Nonomura; Reiko Kishi
Journal:  Environ Health Perspect       Date:  2016-05-24       Impact factor: 9.031

9.  Perfluorooctanesulfonate (PFOS)-induced Sertoli cell injury through a disruption of F-actin and microtubule organization is mediated by Akt1/2.

Authors:  Ying Gao; Haiqi Chen; Xiang Xiao; Wing-Yee Lui; Will M Lee; Dolores D Mruk; C Yan Cheng
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.